Curry spice holds clues to Alzheimer's drug targets

January 12, 2018, Alzheimer's Research UK

Californian researchers have shed more light on the action of an experimental Alzheimer's drug based on a modified component of the curry spice turmeric. The researchers from the Salk Institute, found that the drug, J147, targets cell processes in the mitochondria – an area of the cell responsible for generating the energy. The results are published in the journal Aging Cell.

Dr. Sara Imarisio, Head of Research at Alzheimer's Research UK, said:

"This study suggests the J147 may provide a boost to the molecular battery that powers a cell and in doing so, hold back certain age-related changes and keep working better for longer. While diseases like Alzheimer's are associated with age, they are not a normal part of ageing and are caused by distinct and complex processes in the brain.

"Understanding how a potential new drug affects cells is an important step in the research process, but the ultimate test has to be how it impacts people's lives. This compound has not yet been tested in people, so we will need to see much more research before we can draw conclusions about its benefit against complex diseases like Alzheimer's. While the J147 drug is based on a component of a curry spice, there is no good evidence to suggest that eating turmeric or curry could prevent or treat dementia in people.

"To have the best chance of ending the long wait for new treatments, researchers will need to follow as many leads as possible, creating a diverse pipeline of potential targets for further development."

Explore further: Researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer's disease

Related Stories

Researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer's disease

January 9, 2018
The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans. Now, Salk scientists have solved ...

Experimental drug targeting Alzheimer's disease shows anti-aging effects

November 12, 2015
Salk Institute researchers have found that an experimental drug candidate aimed at combating Alzheimer's disease has a host of unexpected anti-aging effects in animals.

Diabetes drug 'significantly reverses memory loss' in mice with Alzheimer's

January 1, 2018
A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action.

Alzheimer's drug candidate may be first to prevent disease progression

December 14, 2011
A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS One.

Spice ingredient in curry emerges as promising basis for an Alzheimer's disease medicine

August 1, 2012
The spice compound that gives curry dishes their yellow color and pungent flavor is emerging as a prime candidate for a less expensive treatment for Alzheimer's disease (AD), according to an article in the current edition ...

Scientists develop drug that slows Alzheimer's in mice

May 13, 2013
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, published May 14 ...

Recommended for you

New study highlights Alzheimer's herpes link, experts say

July 12, 2018
A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018
Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

The 'Big Bang' of Alzheimer's: Scientists ID genesis of disease, focus efforts on shape-shifting tau

July 10, 2018
Scientists have discovered a "Big Bang" of Alzheimer's disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.

'Skinny fat' in older adults may predict dementia, Alzheimer's risk

July 5, 2018
A new study has found that "skinny fat—the combination of low muscle mass and strength in the context of high fat mass—may be an important predictor of cognitive performance in older adults. While sarcopenia, the loss ...

Pathway of Alzheimer's degeneration discovered

July 5, 2018
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer's disease, uncovering a pathway through which degeneration ...

Brain study paves way for therapy for common cause of dementia

July 4, 2018
Scientists have uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.